This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Franz-Rainer Weitzel: Innovator in Propellant-Free Aerosol Formulations
Introduction
Franz-Rainer Weitzel is a notable inventor based in Schwabenheim, Germany. He has made significant contributions to the field of inhalation therapies, particularly through his innovative work on aerosol formulations. His expertise and dedication to improving patient care have led to the development of a unique formulation that enhances the delivery of medication.
Latest Patents
Weitzel holds a patent for a propellant-free aerosol formulation for inhalation. This invention specifically contains ipratropium bromide and salbutamol, which are essential for treating respiratory conditions. The formulation aims to provide an effective alternative to traditional aerosol delivery methods, ensuring that patients receive their medication without the use of propellants.
Career Highlights
Franz-Rainer Weitzel is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role at the company allows him to collaborate with other experts in the field and contribute to the development of innovative therapies. His work has been instrumental in advancing inhalation technology and improving treatment options for patients.
Collaborations
Weitzel has worked closely with his coworker, Christel Schmelzer, to further enhance the research and development of aerosol formulations. Their collaboration has been vital in refining the formulation and ensuring its efficacy in clinical applications.
Conclusion
Franz-Rainer Weitzel's contributions to the field of inhalation therapies through his propellant-free aerosol formulation exemplify his commitment to innovation in medicine. His work continues to impact the lives of patients who rely on effective respiratory treatments.